Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells

Breast Cancer Research

Volumn 13, Issue 3, 2011, Pages

  Shackleford, Terry J ^a   Zhang, Qingxiu ^a   Tian, Ling ^a   Vu, Thuy T ^a   Korapati, Anita L ^a   Baumgartner, Angela M ^a   Le, Xiao Feng ^a   Liao, Warren S ^a   Claret, Francois X ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN BETA; COP9 SIGNALOSOME; COP9 SIGNALOSOME 5; INTERLEUKIN 6; JUN ACTIVATION DOMAIN BINDING PROTEIN 1; SMALL INTERFERING RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR GATA; TRANSCRIPTION FACTOR GATA 1; UNCLASSIFIED DRUG; C/EBPBETA1 PROTEIN, HUMAN; CCAAT ENHANCER BINDING PROTEIN; COPS5 PROTEIN, HUMAN; DNA BINDING PROTEIN; GATA1 PROTEIN, HUMAN; PEPTIDE HYDROLASE; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; STAT3 PROTEIN, HUMAN;

5' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; BREAST CARCINOMA; CARCINOMA CELL; CHROMATIN IMMUNOPRECIPITATION; CLONING; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE DELETION; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; BREAST TUMOR; DNA SEQUENCE; DRUG ANTAGONISM; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REGULATORY SEQUENCE; RNA INTERFERENCE; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

BASE SEQUENCE; BINDING SITES; BREAST NEOPLASMS; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PEPTIDE HYDROLASES; PROMOTER REGIONS, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID; RNA INTERFERENCE; RNA, SMALL INTERFERING; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 79959248593     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2902     Document Type: Article

References (42)

1. Claret FX, Hibi M, Dhut S, Toda T, Karin M. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 1996, 383:453-457. 10.1038/383453a0, 8837781.
2. Schwechheimer C, Deng XW. COP9 signalosome revisited: a novel mediator of protein degradation. Trends Cell Biol 2001, 11:420-426. 10.1016/S0962-8924(01)02091-8, 11567875.
3. Chamovitz DA, Segal D. JAB1/CSN5 and the COP9 signalosome. A complex situation. EMBO Rep 2001, 2:96-101. 10.1093/embo-reports/kve028, 1083824, 11258719.
4. Shackleford TJ, Claret FX. JAB1/CSN5: a new player in cell cycle control and cancer. Cell Div 2010, 5:26. 10.1186/1747-1028-5-26, 2976740, 20955608.
5. Cope G, Suh GS, Aravind L, Schwarz SE, Zipursky SL, Koonin EV, Deshaies RJ. Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1. Science 2002, 298:608-611. 10.1126/science.1075901, 12183637.
6. Wei N, Serino G, Deng XW. The COP9 signalosome: more than a protease. Trends Biochem Sci 2008, 33:592-600. 10.1016/j.tibs.2008.09.004, 18926707.
7. Tomoda K, Kubota Y, Kato J. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 1999, 398:160-165. 10.1038/18230, 10086358.
8. Bech-Otschir D, Kraft R, Huang X, Henklein P, Kapelari B, Pollmann C, Dubiel W. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. Embo J 2001, 20:1630-1639. 10.1093/emboj/20.7.1630, 145508, 11285227.
9. Oh W, Lee EW, Sung YH, Yang MR, Ghim J, Lee HW, Song J. Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2. J Biol Chem 2006, 281:17457-17465. 10.1074/jbc.M601857200, 16624822.
10. Wan M, Cao X, Wu Y, Bai S, Wu L, Shi X, Wang N. Jab1 antagonizes TGF-beta signaling by inducing Smad4 degradation. EMBO Rep 2002, 3:171-176. 10.1093/embo-reports/kvf024, 1083965, 11818334.
11. Bae MK, Ahn MY, Jeong JW, Bae MH, Lee YM, Bae SK, Park JW, Kim KR, Kim KW. Jab1 interacts directly with HIF-1alpha and regulates its stability. J Biol Chem 2002, 277:9-12.
12. Wei N, Deng XW. The COP9 signalosome. Annu Rev Cell Dev Biol 2003, 19:261-286. 10.1146/annurev.cellbio.19.111301.112449, 14570571.
13. Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tai Y, Tokuda M. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial overian tumors. Clin Cancer Res 2001, 7:4130-4135.
14. Kouvaraki MA, Tian L, Mansouri A, Zhang Q, Kumar R, Kittas C, Claret FX. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1). Cancer Res 2003, 63:2977-2981.
15. Rassidakis GZ, Claret FX, Lai R, Zhang Q, Sarris AH, McDonnell TJ, Medeiros LJ. Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma. Clin Cancer Res 2003, 9:1121-1128.
16. Shintani SLC, Mihara M, Hino S, Nakashiro K, Hamakawa H. Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas. Oncology 2003, 65:355-362. 10.1159/000074649, 14707456.
17. Dong Y, Sui L, Watanabe Y, Yamaguchi F, Hatano N, Tokuda M. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas. Clin Cancer Res 2005, 11:259-266.
18. Richardson KS, Zundel W. The emerging role of the COP9 signalosome in cancer. Mol Cancer Res 2005, 3:645-653. 10.1158/1541-7786.MCR-05-0233, 2943958, 16380502.
19. Adler AS, Lin M, Horlings H, Nuyten DS, van de Vijver MJ, Chang HY. Genetic regulators of large-scale transcriptional signatures in cancer. Nat Genet 2006, 38:421-430. 10.1038/ng1752, 1435790, 16518402.
20. Adler AS, Littlepage LE, Lin M, Kawahara TL, Wong DJ, Werb Z, Chang HY. CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression. Cancer Res 2008, 68:506-515. 10.1158/0008-5472.CAN-07-3060, 2646416, 18199546.
21. Hsu MC, Chang HC, Hung WC. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells. Endocr Relat Cancer 2007, 14:655-667. 10.1677/ERC-07-0077, 17914096.
22. Mansouri A, Ridgway LD, Korapati AL, Zhang Q, Tian L, Wang Y, Siddik ZH, Mills GB, Claret FX. Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J Biol Chem 2003, 278:19245-19256. 10.1074/jbc.M208134200, 12637505.
23. Nikolov DB, Burley SK. RNA polymerase II transcription initiation: a structural view. Proc Natl Acad Sci USA 1997, 94:15-22. 10.1073/pnas.94.1.15, 33652, 8990153.
24. Numata A, Shimoda K, Kamezaki K, Haro T, Kakumitsu H, Shide K, Kato K, Miyamoto T, Yamashita Y, Oshima Y, Nakajima H, Iwama A, Aoki K, Takase K, Gondo H, Mano H, Harada M. Signal transducers and activators of transcription 3 augments the transcriptional activity of CCAAT/enhancer-binding protein alpha in granulocyte colony-stimulating factor signaling pathway. J Biol Chem 2005, 280:12621-12629.
25. Zahnow CA. CCAAT/enhancer binding proteins in normal mammary development and breast cancer. Breast Cancer Res 2002, 4:113-121. 10.1186/bcr428, 138725, 12052253.
26. Ramji DP, Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 2002, 365:561-575. 1222736, 12006103.
27. Grimm SL, Rosen JM. The role of C/EBPbeta in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 2003, 8:191-204. 10.1023/A:1025900908026, 14635794.
28. Bundy LM, Sealy L. CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture. Oncogene 2003, 22:869-883. 10.1038/sj.onc.1206216, 12584567.
29. Lowry JA, Mackay JP. GATA-1: one protein, many partners. Int J Biochem Cell Biol 2006, 38:6-11. 10.1016/j.biocel.2005.06.017, 16095949.
30. Crispino JD. GATA1 in normal and malignant hematopoiesis. Semin Cell Dev Biol 2005, 16:137-147. 10.1016/j.semcdb.2004.11.002, 15659348.
31. Zahnow CA. CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases. Expert Rev Mol Med 2009, 11:e12. 3095491, 19351437.
32. Singh SP, Lipman J, Goldman H, Ellis FH, Aizenman L, Cangi MG, Signoretti S, Chiaur DS, Pagano M, Loda M. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res 1998, 58:1730-1735.
33. Clevenger CV. Roles and regulation of stat family transcription factors in human breast cancer. Am J Pathol 2004, 165:1449-1460. 10.1016/S0002-9440(10)63403-7, 1618660, 15509516.
34. Horvath CM, Wen Z, Darnell JE. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev 1995, 9:984-994. 10.1101/gad.9.8.984, 7774815.
35. Xu X, Sun YL, Hoey T. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 1996, 273:794-797. 10.1126/science.273.5276.794, 8670419.
36. Kaptein A, Paillard V, Saunders M. Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction. J Biol Chem 1996, 271:5961-5964. 10.1074/jbc.271.11.5961, 8626374.
37. Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J, Jove R. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 1995, 269:81-83. 10.1126/science.7541555, 7541555.
38. Reddy EP, Korapati A, Chaturvedi P, Rane S. IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled. Oncogene 2000, 19:2532-2547. 10.1038/sj.onc.1203594, 10851052.
39. Eaton EM, Hanlon M, Bundy L, Sealy L. Characterization of C/EBPbeta isoforms in normal versus neoplastic mammary epithelial cells. J Cell Physiol 2001, 189:91-105. 10.1002/jcp.1139, 11573208.
40. Yu H, Jove R. The STATs of cancer--new molecular targets come of age. Nat Rev Cancer 2004, 4:97-105. 10.1038/nrc1275, 14964307.
41. Irby RB, Yeatman TJ. Role of Src expression and activation in human cancer. Oncogene 2000, 19:5636-5642. 10.1038/sj.onc.1203912, 11114744.
42. Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB, Sung B, Ichikawa H. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci 2006, 1091:151-169. 10.1196/annals.1378.063, 17341611.